BFB-101

N/A

Report date: 2025/05/06 20:00:08

Base Information

Drug NameBFB-101
Drug Alias NameBFB-101
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector > AAV9 vector
Mechanisms of ActionGene transferenceAdaptor Related Protein Complex 4 Subunit Beta 1 modulators
TargetsAdaptor Related Protein Complex 4 Subunit Beta 1
Therapy Area/IndicationsNeurodevelopmental DisordersParaplegiaSpastic Paraplegia, Hereditary +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesBlackfinBio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBlackfinBio Ltd
Inactive CompaniesN/A
Active IndicationsNeurodevelopmental DisordersParaplegiaSpastic Paraplegia, Hereditary +[4] 
Inactive IndicationsNervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A